Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

roerig - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - zoloft is indicated for the treatment of the following [see clinical studies (14)] : zoloft is contraindicated in patients: in addition to the contraindications for all zoloft formulations listed above, zoloft oral solution is contraindicated in patients: overall, available published epidemiologic studies of pregnant women exposed to sertraline in the first trimester suggest no difference in major birth defect risk compared to the background rate for major birth defects in comparator populations. some studies have reported increases for specific major birth defects; however, these study results are inconclusive [see data] . there are clinical considerations regarding neonates exposed to ssris and snris, including zoloft, during the third trimester of pregnancy [see clinical considerations] . although no teratogenicity was observed in animal reproduction studies, delayed fetal ossification was observed when sertraline was administered during the period of organogenesis at doses less than the maximum recommende

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - escitalopram oxalate (unii: 5u85dbw7lo) (escitalopram - unii:4o4s742any) - escitalopram 5 mg in 5 ml - escitalopram oral solution is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [see clinical studies (14.1) ]. a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. escitalopram oral solution is indicated for the acute treatment of generalized anxiety disorder (gad) in adults [see clinical studies (14.2) ]. generalized anxiety disorder (dsm-iv) is characterized by excessive anxiety and worry (apprehensive expectation) that is persisten

Jaunzēlande - angļu - Ministry for Primary Industries

schering-plough animal health limited - levothyroxine sodium pentahydrate - levothyroxine sodium pentahydrate 1 g/litre - endocrine agent (hormone)

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - enrofloxacin - oral solution/suspension - enrofloxacin antibiotic active 25.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial infection | infections of the respiratory tract | infections of the urinary tracts | infectious sinusitis | staphylococcus intermedius | wound infections | abscesses | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | deep pyodermas | discharging sinuses | escherichia coli | gram negative organisms | gram positive organisms | group d streptococcus | including secondary invaders | klebsiella spp. | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | proteus spp. | pseudomonas aeruginosa | seborrhoeic dermatitis | staphylococcus spp. | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - levothyroxine sodium 1 mg/ml - eq. levothyroxine 0,97 mg/ml - oral solution - 1 mg/ml - levothyroxine sodium 1 mg/ml - levothyroxine sodium - dog

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ecolab pty ltd - calcium, magnesium and potassium-salts of arabic acid - oral solution/suspension - calcium, magnesium and potassium-salts of arabic acid emulsifiers & surfactants active 969.0 g/l - alimentary system - cattle | trough | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bloat | water treatment/sanitiser | bloated | colic | frothy bloat | gas colic | legume bloat | weight gain

Īrija - angļu - HPRA (Health Products Regulatory Authority)

norton healthcare limited t/a ivax pharmaceuticals uk - haloperidol - oral solution - 2 mg/ml

Kanāda - angļu - Health Canada

intervet canada corp - levothyroxine sodium - solution - 1mg - levothyroxine sodium 1mg - dogs

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

par pharmaceutical - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg - penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g- sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections (without bacteremia): mild-to-moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections : mild to moderately severe infections of the respiratory tract. staphylococcal infections - penicillin g sensi

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - carbidopa monohydrate, quantity: 40.5 mg (equivalent: carbidopa, qty 37.5 mg); entacapone, quantity: 200 mg; levodopa, quantity: 150 mg - tablet, film coated - excipient ingredients: trehalose dihydrate; hyprolose; magnesium stearate; microcrystalline cellulose; sodium sulfate; carmellose sodium; powdered cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.